中国创新药企CEO集体亮相BIOCHINA美国站 | 让中国管线，对话全球
2026年5月7日
BIOCHINA Global Forum@USA即将于6月21日登陆美国圣地亚哥，聚焦全球产业链协同，并将首次在美启用约见系统，搭建中美及全球企业高效对接桥梁。
此前，17Talk易企说在MNC同台论道、欧美药企释放约见需求，从BD到CMC的全链条扩容等方面介绍了2026BIOCHINA美国站的新动态新发展——
- 拜耳、罗氏、第一三共、阿斯利康重磅同台：共议MNC商业化新动向
- 爱尔兰、美国、欧洲医药企业释放合作需求！来BIOCHINA美国站现场约见
- 从BD到CMC，BIOCHINA Global Forum美国站再扩容！
也正是基于此，聚焦在TCE、ADC、AI制药、In Vivo CAR-T、mRNA等前沿技术赛道的中国创新药企CEO们将聚首BIOCHINA美国站，面向全球生物医药同仁，分享企业管线与技术思考。
New Drug Development and Innovation Focus
13:40-14:25 Panel Discussion: How to Establish Global R&D Advantages
Panelists: Gang Qin, GeneQuantum, CEO
Mingjiu Chen, Biosion, Founder, President & CEO
14:25-14:45 Keynote Speech：T-cell Engager Development：From Innovation to Therapeutic Impact
Speaker: Julie Bailis, Vice President, Head of Oncology Research, Amgen Inc.
14:45-15:05 Keynote Speech: Differentiated Design & Development of ADCs
Speaker: Tony Xue, MediLink Therapeutics, Founder & CEO
15:05-15:25 Keynote Speech: Research on Bispecific Dual-Toxin ADCs
Speaker: Zhaoyuan Chen, Phrontline Biopharma, CEO
15:25-15:55 Tea Break & Networking
15:55-16:15 Keynote Speech: Al Driven: Precise Desian and Efficient R&D of Molecular Glues
Speaker: Lily Zou, Degron Therapeutics Inc., Co-Founder & CEO
16:15-16:35 Keynote Speech: R&D Strategies and Recent Clinical Advances of In Vivo CAR-T Therapy
Speaker: Minmin Sun, Immunofoco Biotechnology Co., Ltd., Founder, Chairman & CEO
16:35-16:55 Keynote Speech: Clinical Exploration and Key Breakthroughs of mRNA Cancer Therapeutic Vaccines
Speaker: Jane Wang, Salubris Pharmaceuticals, CSO